好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Tumefactive Acute Disseminated Encephalomyelitis-Like Pathology: A Rare Presentation of Q Fever
Infectious Disease
P2 - Poster Session 2 (2:45 PM-3:45 PM)
061

Recognize tumefactive demyelination as neurological manifestation of acute Q fever.

Q fever is a zoonotic infection from Coxiella burnetii, a gram-negative obligate intracellular bacterium. Acute infection presents asymptomatically or as self-limited illness (fever, headache) with hepatic and pulmonary involvement. This case describes tumefactive demyelination secondary to recent Q fever infection.

This case report documents a previously healthy 35-year-old male without farm exposure, who consumes queso fresca. He presented with one-week increasing confusion and dysdiadokinesia with studies revealing basal ganglia perivascular demyelination in the setting of acute Q fever.

MRI brain demonstrated multiple ring-enhancing lesions within the basal ganglia (largest 2.1 by 1.1 cm) with surrounding T2/FLAIR hyperintensities and heterogenous internal enhancement, diffusion restriction, and hemosiderin. Since lumbar puncture was unremarkable for infection and confusion persisted despite empiric antibiotics, the right basal ganglia lesion was biopsied, revealing only reactive gliosis and perivascular histiocyte infiltration. Based on epidemiological risk factors and one AFB-positive sputum culture, antituberculosis therapy (RIPE) and dexamethasone were empirically started for possible tuberculoma. Mental and physical symptoms improved post-discharge, even after discontinuing RIPE once cultures speciated to Mycobacteria stomatepiae. Serum studies collected 2.5 weeks after presentation returned positive for Coxiella burnetii (phase II IgG 1:64). Repeat titers collected 6 weeks later demonstrated a four-fold increase (phase II IgG 1:256), consistent with acute Q fever, and doxycycline was initiated. 

This case describes a previously unreported association between Q fever and tumefactive ADEM-like demyelination. This presentation of multiple ring-enhancing lesions initially raised concern for primary infection, septic emboli, or lymphoma. However, without infection or atypical lymphocytes on pathology, observed histiocytes and suggested perivascular demyelination supported secondary tumefactive ADEM-like pathology, which clinically responded to steroids. Follow-up MRI is planned, pending insurance authorization. Given reports describing encephalomyelitis and demyelinating polyneuropathy with acute Q fever, Coxiella burnetii testing should be considered in tumefactive demyelination.

Authors/Disclosures
Nikash Shankar, MD (UNC Hospitals)
PRESENTER
Dr. Shankar has received personal compensation for serving as an employee of Medstar Georgetown.
Jessica T. Lin The institution of Dr. Lin has received research support from NIH.
Benjamin Cho Benjamin Cho has nothing to disclose.
Faris R. Almubaslat, MD, MPH Dr. Almubaslat has nothing to disclose.
Jonathan B. Parr, MD Dr. Parr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zymeron Corporation. The institution of Dr. Parr has received research support from Gilead Sciences.
Michael Herce, MD The institution of Dr. Herce has received research support from NIH.
Andrea Bozoki, MD, FAAN (University of North Carolina) Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creative Biopeptides. Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. The institution of Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AviadoBio. The institution of Dr. Bozoki has received research support from Cognition Therapeutics. The institution of Dr. Bozoki has received research support from EIP Pharma. The institution of Dr. Bozoki has received research support from Transposon Therapeutics. The institution of Dr. Bozoki has received research support from Alector .
Monica M. Diaz, MD, MS (University of North Carolina at Chapel Hill) The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.